Английская Википедия:Epiboxidine

Материал из Онлайн справочника
Версия от 01:52, 4 марта 2024; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{Short description|Chemical compound}} {{Drugbox | IUPAC_name = (''1R'',''4S'',''6S'')-6-(3-Methylisoxazol-5-yl)-7-azabicyclo[2.2.1]heptane | image = Epiboxidine skeletal.svg <!--Clinical data--> | tradename = | pregnancy_category = | legal_status = Investigational | routes_of_administration = <!--Pharmacokinetic data--> | bioavailability = | protein_bound = | metabolism...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

Epiboxidine is a chemical compound which acts as a partial agonist at neural nicotinic acetylcholine receptors, binding to both the α3β4 and the α4β2 subtypes. It was developed as a less toxic analogue of the potent frog-derived alkaloid epibatidine, which is around 200 times stronger than morphine as an analgesic but produces extremely dangerous toxic nicotinic side effects.

Epiboxidine is around one-tenth as potent as epibatidine as an α4β2 agonist, but has around the same potency as an α3β4 agonist. It has only one-tenth of the analgesic power of epibatidine, but is also much less toxic.[1][2][3]

Uses

Despite its decreased potency and toxicity compared to epibatidine, epiboxidine itself is still too toxic to be developed as a drug for use in humans. It is used in scientific research[4] and as a parent compound to derive newer analogues which may be safer and have greater potential for clinical development.[5][6][7]

See also

References

Шаблон:Reflist

Шаблон:Stimulants Шаблон:Analgesics Шаблон:Nicotinic acetylcholine receptor modulators